Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aurolife Pharma
Dayton, New Jersey, United Statesaurolifepharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Aurolife has received US FDA approval for multiple ANDAs and manufactures a wide array of generic pharmaceuticals. The company operates cGMP-compliant facilities with DEA authorization for controlled substances. Recent FDA inspections have resulted in procedural observations but no material impact on operations.
- Therapeutic areas
- NeurologyDermatologyOncologyOtherCardiovascular
- Modalities
- Small moleculeOral solid dosage formsInhalersDermatological products
- Industry
- Biotech
02
Partnerships
Not explicitly stated; main relationship is vertical integration within the Aurobindo group.
Beyond the preview
Go deeper on Aurolife Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aurolife Pharma.